Bill119th CongressFiled Jan 23, 2025Health
H.R. 679
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it does
A plain-language summary from the Congressional Research Service isn’t available yet for this bill. CRS summaries are typically posted within a few weeks of introduction.
What just happenedJan 23, 2025
Referred to the House Committee on Energy and Commerce.
Who’s behind it
Rep. Harshbarger, Diana [R-TN-1](R-TN)Sponsor
18 cosponsors18 R
18cosponsors1committees3actions4subjects
- Introduced in HouseJan 23, 2025
- Jan 23, 2025IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Jan 23, 2025IntroReferralIntro-H
Introduced in House
- Jan 23, 2025IntroReferral1000
Introduced in House